FDA Inspection
Paul Schulz, M.D.Paul Schulz, M.D. – FDA Inspection, Jul 22, 2025
Record Details
This FDA Inspection record concerns Paul Schulz, M.D., with an inspection on July 22, 2025, issued by the Dallas District Office, covering human drugs.
View Company Profile
ID · 701d1a8e-9863-4ed7-abae-fbbd380a3eaa
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1276292
- FDA center
- Human Drugs
- Project area
- Bioresearch Monitoring: Human Drugs
FDA Citations
3- 21 CFR 312.60Informed consent
- 21 CFR 312.50General responsibilities of sponsors
- 21 CFR 312.62(b)Case history records- inadequate or inadequate
Full citation text and observation details available on the Dashboard.
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.